Диссертация (1140122), страница 20
Текст из файла (страница 20)
ActaPsychiat Scand. 1987;76:89-93.73.Bowers M.B., Astrachan B.M. Depression in acute schizophrenia psychosis. AmJ Psychiatry. 1967;123:976–9.74.Bucci L. The negative symptoms of schizophrenia and monoamine oxidaseinhibitors. Psychopharmacology. 1987;91(1):104-8.75.Buckley P.F., Miller B.J., Lehrer D.S., Castle D.J. Psychiatric Comorbidities andSchizophrenia. Schizophr Bull. 2009;35(2):383-402.76.Carpenter W., Heinrichs D.W., Alphs L.D.
Treatment of Negative Symptoms.Schizophrenia Bulletin. 1985;11(3):440-52.77.Chemerinski E., Bowie C., Anderson H., Harvey P.D. Depression inSchizophrenia: Methodological artifact or distinct feature of the illness? JNeuropsychiat Clin Neurosciences. 2008;20:431-40.78.Craddock N., Owen M.J. The Kraepelinian dichotomy – going, going...
but stillnot gone. Brit J Psychiat. 2010;196(2):92–5.11179.Craig T.J. et al. Measurement of mood and affect in schizophrenic inpatients.American Journal of Psychiatry. 1985;142(11):1272-77.80.Crow T. A current view of the Type II Syndrome. British Journal of Psychiatry.1989;155(7):15-20.81.De Alarcon R., Carney M.W.P. Severe depressive mood changes following slowrelease intramuscular fluphenazine injection. Brit Med J.
1969;3:564-7.82.Docherty N.M. Affective reactivity of symptoms as a process discriminator inschizophrenia. Journal of Nervous and Mental Diseases. 1996;184(9):53-4.83.Drake R.F., Cotton P.G. Depression, hopelessness, and suicide in chronicschizophrenia. Brit J Psychiat. 1986;148:554-9.84.Floru L., Heinrich K., Wittek F. The problem of postpsychotic schizophrenicdepression and their pharmacological induction. Int Pharmacopsychiat.1975;10:230-9.85.Frank E., Kupfer D.J., Perel J.M. Early recurrent in depression.
Archives ofGeneral Psychiatry. 1989;46(5):397-400.86.Galdi J. The causality of depression in schizophrenia. Brit J Psychiat.1983;142:621-5.87.Galdi J., Rieder R.O., Silber D., Bonato R.R. Genetic factors in the response toneuroleptics in schizophrenia: a pharmacogenetic study. Psychol Med.1981;11:713-28.88.Ganesan S., Eggens I., Huizar K., Meulien D. Switching from antipsychotic toquetiapine XR treatment in patients with schizophrenia and high or lowdepression symptoms. Eur Psychiatry.
2009;24(1):1140.89.Górna K., Jaracz K., Wrzyszczyńska L., Rybakowski F. Quality of life anddepression in schizophrenic patients. Advances Med Sciences. 2007;52(1):10811.90.Green M.F., Nuechterlein K.H., Ventura J., Mintz J. The temporal relationshipbetween depressive and psychotic symptoms in recent-onset schizophrenia. Am JPsychiatry. 1990;147:179-82.11291.Harrow M., Fichtner C.G., Grossman L.S. et al. Neuroleptic depression inschizophrenia. Biolog Psychiat. 1991;30:845-7.92.Harrow M., Grinker R., Holzman P., Kayton L. Anhedonia and schizophrenia.Am J Psychiatry.
1977;134:794-7.93.Hirsch S.R., Gaind R., Rohde P.D., Stevens B.C., Wing J.T.: Outpatientmaintenance of chronic schizophrenic patients with long-acting fluphenazine:double-blind placebo trial. Br Med J. 1973;1:633-794.Hirsch S.R., Jolley A.G., Barnes T.R.E. et al. Dysphoric and depressivesymptoms in chronic schizophrenia.
Schizophr Res. 1989;2:259-64.95.Hoedemaker F.S. Psychotic episodes and postpsychotic depression in youngadults. Am J Psychiatry. 1970;127:606-10.96.Hogarty G.E., Munetz M.R. Pharmacogenic depression among outpatientschizophrenic patients: a failure to substantiate. J Clin Psychopharmacol.1984;4:17-24.97.House A., Bostock J., Cooper J.
Depressive syndromes in the year followingonset of first schizophrenic illness. Brit J Psychiat. 1987;151:773-9.98.Innamorati M., Baratta S., di Vittorio C. et al. Atypical Antipsychotics in theTreatment of Depressive and Psychotic Symptoms in Patients with ChronicSchizophrenia: A Naturalistic Study Schizophr Res Treatment. 2013;423205.99.Jacob M.
et al. Recurrent depression. An assessment of family burden and familyattitudes. Journal of Clinical Psychiatry. 1987;48(11):395-400.100. Johnson D.A. Studies of depressive symptoms in schizophrenia. I. The prevalenceof depression and its possible causes. Brit J Psychiat. 1981;139:89-101.101. Johnson D.A. Significance of depression in the prediction of relapse in chronicschizophrenia. Brit J Psychiat 1988;152:320-3.102. Johnson D.A.W. Depressions in schizophrenia: some observations on prevalence,etiology, and treatment. Acta Psychiatr Scand Suppl. 1981;291:137-44103.
Kim S.W., Shin I.S., Kim J.M. et al. Amisulpride versus risperidone in thetreatment of depression in patients with schizophrenia: A randomized, open-label,113controlledtrial.ProgressNeuro-PsychopharmacolBiolPsychiatry.2007;31(7):1504-9.104. Kirli S., Çaliskan M. A comparative study of sertraline versus imipramine inpostpsychotic depressive disorder of schizophrenia. Schizophrenia Research.1998;33(1-2):103-11105. Knights A., Hirsch S.R.: “Revealed” depression and drug treatment forschizophrenia. Arch Gen Psychiatry. 1981;38:806–811106.
Leff J. Depressive symptoms in the course of schizophrenia. In: L. De Lisi (ed).Depression in Schizophrenia. Washington:1990;3-23.107. Lindenmayer J., Kay S.R. et al. Schizophrenic patients with depression:psychopathological profiles and the relationship with negative symptoms. ComprPsychiatry. 1991;32:528-33.108. Lindenvager J.P. et al.
Schizophrenic patients with depression. Compr Psychiatry.1991;32(6):528-33.109. Mackinnon B.L. Postpsychotic depression and the need for personal significance.Am J Psychiatry. 1977;134(4):427-9.110. Mandel M.R., Severe J.B., Schooler N.R. et al. Development and prediction ofpost psychotic depression in neuroleptic treated schizophrenics.
Arch GenPsychiat. 1982;39:197-203.111. Marques T.R., Levine S.Z., Reichenberg A. et al. How antipsychotics impact thedifferent dimensions of Schizophrenia: a test of competing hypotheses. EurNeuropsychopharmacol. 2014;24(8):1279-88.112. Martin R.L., Cloninger C.R., Guze S.B., Clayton P.B.
Frequency and differentialdiagnosis of depressive syndromes in schizophrenia. J Clin Psychiat.1985;46(11):9-13.113. Mauri M.C.etal. Depressivesymptomsandschizophrenia:apsychopharmacological approach. Encephale. 1995;21(5):555-8.114. Mazeh D., Shahal B., Saraf R., Melamed Y. Venlafaxine for the treatment ofdepressive episode during the course of schizophrenia.
J Clin Psychopharmacol.2004;24(6):653-5.114115. McGlashan T., Carpenter W.T. An investigation of the postpsychotic depressivesyndrome. Am J Psychiatry. 1976;133:14-8.116. McGlashan T., Carpenter W.T. Postpsychotic depression in schizophrenia. ArchGen Psychiat. 1976;33:231-9.117. McGlashan T., Carpenter W.T. Affective symptoms and the diagnosis ofschizophrenia. Schizophr Bull. 1979;5(5):547-53.118. Möller H.J., von Zerssen D.: Depressive states occurring during the neuroleptictreatment of schizophrenia. Schizophr Bull. 1982;8:109-17119. Morrissette D.A., Stahl S.M. Affective symptoms in schizophrenia.
DrugDiscovery Today: Therapeutic Strategies. 2011;8(1-2):3-9.120. Mueller P.S. Increasing rates of depression. Journal of American MedicalAssociation. 1989;262(7):899.121. Mulholland C., Cooper S. The symptom of depression in schizophrenia and itsmanagement. Advanc Psychiat Treatment. 2000;6:169-77.122. Nakajima S., Takeuch I.H., Fervaha G. et al. Comparative efficacy betweenclozapine and other atypical antipsychotics on depressive symptoms in patientswith schizophrenia: Analysis of the CATIE phase 2E data. Schizoph Res.2015;161(2-3):429-33.123.
Planansky K., Johnston R. Depressive syndrome in schizophrenia. Acta PsychiatScand. 1978;57:207-18.124. Planansky K., Johnston R. Psychotropic drugs and depressive syndrome inschizophrenia. Psych Quart. 1980;52:214125. PlaskyP.Antidepressantusageinschizophrenia.SchizophrBull.1991;17(4):649-57126. Rada R.T., Donlon P.J. Depression and the acute schizophrenic process. JPsychosomatics. 1975;16:116-9.127. Richardson M.A. et al. Tardive dyskinesia and depressive syndrome inschizophrenics. Psychopharmacology Bulletin.
1985;21(1):130-5.128. Richman J., Flaherty J. Coping and depression . Journal of Nervous and MentalDiseases. 1985;173(10):590-5.115129. Riedel M., Mayr A., Seemuller F. et al. Depressive symptoms and theirassociation with acute treatment outcome in first-episode schizophrenia patients:comparing treatment with risperidone and haloperidol.
World J Biol Psychiatry.2012;13:30-8.130. Rifkin A. Akinesia. Arch Gen Psychiat. 1975;32:672-4.131. Roth S. The seemingly ubiquitous depression following acute shizophrenicepizodes, a neglected area of clinical discussion. Amer J Psychiat.1970;127(1):51-8.132. Roy A. Do neuroleptics cause depression? Biol Psychiatry. 1984;19:777-81133.
Roy A., Thompson R., Kennedy S. Depression in chronic schizophrenia. Brit JPsychiat. 1983;142:465-70.134. Roy A. Depression, attempted suicide, and suicide in patients with chronicschizophrenia. Psychiatric Clinics of North America. 1986;9(1):193-206.135. Rybakowski J.K., Vansteelandt K., Szafranski T. et al. Treatment of depression infirstepisodeofschizophrenia:ResultsfromEUFEST.EurNeuropsychopharmacol. 2012;22(12):875-82.136.
Schulte J.L. Homicide and suicide associated with akathisia and haloperidol.American Journal of Forensic Psychiatry. 1985;6(2):3-7.137. Shanfield S., Tucker G., Harrow M., Detre T. The schizophrenic patient anddepressivesymptomatolgy.JournalofNervous&MentalDisease.1970;151(3):203-10138. Singh S.P., Singh V., Kar N., Chan K. Efficacy of antidepressants in treating thenegative symptoms of chronic schizophrenia: meta-analysis.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
